121
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We recently showed that dendritic cells (DCs) activated by thymic stromal lymphopoietin (TSLP) prime naive CD4 + T cells to differentiate into T helper type 2 (Th2) cells that produced high amounts of tumor necrosis factor- α (TNF- α), but no interleukin (IL)-10. Here we report that TSLP induced human DCs to express OX40 ligand (OX40L) but not IL-12. TSLP-induced OX40L on DCs was required for triggering naive CD4 + T cells to produce IL-4, -5, and -13. We further revealed the following three novel functional properties of OX40L: (a) OX40L selectively promoted TNF- α, but inhibited IL-10 production in developing Th2 cells; (b) OX40L lost the ability to polarize Th2 cells in the presence of IL-12; and (c) OX40L exacerbated IL-12–induced Th1 cell inflammation by promoting TNF- α, while inhibiting IL-10. We conclude that OX40L on TSLP-activated DCs triggers Th2 cell polarization in the absence of IL-12, and propose that OX40L can switch IL-10–producing regulatory Th cell responses into TNF- α–producing inflammatory Th cell responses.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          The lineage decisions of helper T cells.

          After encountering antigen, helper T (T(H)) cells undergo differentiation to effector cells, which can secrete high levels of interferon-gamma, interleukin-4 (IL-4), IL-10 and other immunomodulators. How T(H) cells acquire, and remember, new patterns of gene expression is an area of intensive investigation. The process is remarkably plastic, with cytokines being key regulators. Extrinsic signals seem to be integrated into cell-intrinsic programming, in what is becoming an intriguing story of regulated development. We summarize the latest insights into mechanisms that govern the lineage choices that are made during T(H)-cell responses to foreign pathogens.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Toll-like receptors control activation of adaptive immune responses.

            Mechanisms that control the activation of antigen-specific immune responses in vivo are poorly understood. It has been suggested that the initiation of adaptive immune responses is controlled by innate immune recognition. Mammalian Toll-like receptors play an essential role in innate immunity by recognizing conserved pathogen-associated molecular patterns and initiating the activation of NF-kappaB and other signaling pathways through the adapter protein, MyD88. Here we show that MyD88-deficient mice have a profound defect in the activation of antigen-specific T helper type 1 (TH1) but not TH2 immune responses. These results suggest that distinct pathways of the innate immune system control activation of the two effector arms of adaptive immunity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.

              T helper lymphocytes can be divided into two distinct subsets of effector cells based on their functional capabilities and the profile of cytokines they produce. The Th1 subset of CD4+ T cells secretes cytokines usually associated with inflammation, such as IFN-gamma and TNF and induces cell-mediated immune responses. The Th2 subset produces cytokines such as IL-4 and IL-5 that help B cells to proliferate and differentiate and is associated with humoral-type immune responses. The selective differentiation of either subset is established during priming and can be significantly influenced by a variety of factors. One of these factors, the cytokine environment, has been put forward as the major variable influencing Th development and is already well reviewed by others. Instead, in the current review, we focus on some of the alternative approaches for skewing Th1/Th2 responses. Specifically, we discuss the effects on Th priming of (a) using altered peptide ligands as antigens, (b) varying the dose of antigen, and (c) altering costimulatory signals. The potential importance of each of these variables to influence immune responses to pathogens in vivo is discussed throughout.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                7 November 2005
                : 202
                : 9
                : 1213-1223
                Affiliations
                [1 ]Center for Cancer Immunology Research, Department of Immunology, The University of Texas M.D. Anderson Cancer Center
                [2 ]The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030
                [3 ]Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan
                [4 ]Allergy Research Laboratory, Research Center of Centre Hospitalier Université de Montreal, Notre Dame Hospital, Montreal, Quebec H2L 4M1, Canada
                [5 ]Tanox, Inc., Houston, TX 77025
                Author notes

                CORRESPONDENCE Yong-Jun Liu: yjliu@ 123456mdanderson.org

                Article
                20051135
                10.1084/jem.20051135
                2213234
                16275760
                e14b5441-9ca7-4625-ae51-b75b195c5bdf
                Copyright © 2005, The Rockefeller University Press
                History
                : 6 July 2005
                : 6 September 2005
                Categories
                Article

                Medicine
                Medicine

                Comments

                Comment on this article